Literature DB >> 1838347

Possible involvement of dopamine D-1 and D-2 receptors in diazepam-induced hyperphagia in rats.

T Naruse1, H Amano, Y Koizumi.   

Abstract

Possible involvement of dopamine receptors in diazepam-induced (1 mg/kg, subcutaneous (sc] hyperphagia was studied in nondeprived rats. Pretreatment with the selective D-1 antagonist, SCH23390 (0.03 mg/kg, sc) inhibited diazepam-induced hyperphagia. In addition, pretreatment with the preferential D-2 antagonists, haloperidol (0.1 to 0.3 mg/kg, sc) and clebopride (0.1 to 0.3 mg/kg, sc) inhibited diazepam-induced hyperphagia in a dose-dependent manner. Pretreatment with co-administration of SCH23390 (0.1 mg/kg, sc) and clebopride (0.03 mg/kg, sc) completely inhibited this hyperphagia. The selective D-2 antagonist, sulpiride (40 mg/kg, sc) and the peripheral D-2 antagonist, domperidone (10 mg/kg, sc) did not affect diazepam-induced hyperphagia. However, sulpiride (10 micrograms, icv) or domperidone (2 micrograms, icv) administered centrally inhibited this hyperphagia. The highest dose of haloperidol (0.3 mg/kg, sc) or clebopride (0.3 mg/kg, sc) and higher doses of SCH23390 (0.01 and 0.03 mg/kg, sc) or SCH23390/clebopride (0.01/0.03 and 0.01/0.1 mg/kg, sc) tended to decrease spontaneous feeding in non-deprived rats. In addition, the highest dose of haloperidol, clebopride or SCH23390/clebopride inhibited spontaneous feeding in deprived rats. Interestingly, diazepam-induced hyperphagia was inhibited significantly by doses of haloperidol (0.1 mg/kg, sc), clebopride (0.1 mg/kg, sc) and SCH23390/clebopride (0.003/0.03 and 0.003/0.1 mg/kg, sc) which did not affect spontaneous feeding in non-deprived or deprived rats. Pretreatment with alpha-methyl-p-tyrosine (40 mg/kg, IP x 2, 6 and 2 h prior to diazepam administration) failed to inhibit this hyperphagia. Furthermore, pretreatment with a large dose of haloperidol (5 mg/kg, sc, 4 days before diazepam administration) augmented the sub-hyperphagic effect to diazepam (0.5 mg/kg, sc). Thus, these findings suggest that hyperphagia to diazepam is mediated in part by both dopamine D-1 and D-2 receptors in non-deprived rats.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1838347     DOI: 10.1111/j.1472-8206.1991.tb00757.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  6 in total

1.  A comparison of the effects of the D1 receptor antagonists SCH 23390 and SCH 39166 on suppression of feeding behavior by the D1 agonist SKF38393.

Authors:  P Terry; J L Katz
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

2.  Effects of the dopamine D1 receptor antagonist SCH 39166 on the ingestive behaviour of alcohol-preferring rats.

Authors:  I Panocka; R Ciccocioppo; M Mosca; C Polidori; M Massi
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

3.  Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.

Authors:  Eva M Marco; María S García-Gutiérrez; Francisco-Javier Bermúdez-Silva; Fabricio A Moreira; Francisco Guimarães; Jorge Manzanares; María-Paz Viveros
Journal:  Front Behav Neurosci       Date:  2011-10-05       Impact factor: 3.558

4.  Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa.

Authors:  Timo Dirk Müller; Kathrin Reichwald; Günter Brönner; Jeanette Kirschner; Thuy Trang Nguyen; André Scherag; Wolfgang Herzog; Beate Herpertz-Dahlmann; Peter Lichtner; Thomas Meitinger; Matthias Platzer; Helmut Schäfer; Johannes Hebebrand; Anke Hinney
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2008-11-17       Impact factor: 3.033

Review 5.  The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction.

Authors:  Maria-Paz Viveros; Francisco-Javier Bermúdez-Silva; Ana-Belén Lopez-Rodriguez; Edward J Wagner
Journal:  Pharmaceuticals (Basel)       Date:  2011-08-10

6.  Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.

Authors:  Tsukasa Nozu; Saori Miyagishi; Rintaro Nozu; Kaoru Takakusaki; Toshikatsu Okumura
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.